Hdl Handle:
Rutinemessig ultralydundersøkelse i svangerskapet
Reinar, Liv Merete; Smedslund, Geir; Fretheim, Atle; Hofmann, Bjørn; Thürmer, Hanne
Rapport fra Kunnskapssenteret 11/2008
Additional Links:

Full metadata record

DC FieldValue Language
dc.contributor.authorReinar, Liv Merete-
dc.contributor.authorSmedslund, Geir-
dc.contributor.authorFretheim, Atle-
dc.contributor.authorHofmann, Bjørn-
dc.contributor.authorThürmer, Hanne-
dc.identifier.citationRapport fra Kunnskapssenteret 11/2008en
dc.description.abstractKEY MESSAGES Routine ultrasound in pregnancy The Norwegian Knowledge Centre for the Health Services was asked to evaluate the clinical effect and the diagnostic value of routine ultrasound in the first, second and third trimester of pregnancy. Today all women are offered an ultrasound in the 17th to 19th week of pregnancy. This routine ultrasound offer information on estimation of term, number of foetuses, detection of placenta praevia and detection of structural abnormalities and foetal develpoment. Based on the research literature we found no additional evidence in favour of introducing additional routine ultrasound in the first trimester (week 11 to 14) or in the third trimester (week 32 til 34) of pregnancy. However, an effect of introducing an early ultrasound is the information it gives if investigating foetuses for increased risk for chromosome abnormalities. If this is the aim, the early ultralsound combined with serum markers is the most effective test. Combined ultrasound and serum markers early in pregnancy give better indication for finding foetous at increased risk for chromosome abnormalitites (and therefore fewer miscarriages due to amniosenteces) than testing based on mothers’ age. Based on our review of the included literature, there does not seem to be any important differences between ultrasound in the first or second trimester with respect to term estimation. When it comes to twin pregnancies, ultrasound in the first trimester will provide added information about mono- or dichorionic placentas. Ultrasound with measurement of nuchal translucency (NT) in week 11+0 to 13+6 supplied with maternal blood tests (CUB), is effective in terms of finding foetuses at increased risk of Down’s syndrome and is associated with a higher sensitivity than ultrasound in second trimester or risk assessment based on maternal age. Severe structural abnormalities (with normal chromosomes) are more effectively detected in the second trimester. There does not seem to be any evidence in favour of routine ultrasound in the third trimester of 11 Rutinemessig ultralydundersøkelse i svangerskapet | Hele rapporten i pdf format: www.kunnskapssenteret.no pregnancy as an addition to ultrasound in the first and/or second trimester on health outcomes. Ultrasound is offered to all pregnant women in weeks 17 to 19 of pregnancy and has a high uptake which indicates that women are in favour of it. Based on the literature included, it does not seem to be the case that screening programmes in the first or second trimester increase levels of anxiety or worries. For women who experience positive findings (increased risk for abnormalities) the level of anxiety increases. Although further investigations or diagnostic tests indicate that the finding was ”false positive”, these women will continue to suffer from a higher level of anxiety than other pregnant women throughout the pregnancy. Newer studies indicate that women are well informed about routine ultrasound in pregnancy, but there are challenges when informing about nuchal translucency (NT) and serum markers. Ultrasound is part of routine antenatal care in Norway and is offered from the 17th to the 19th week of pregnancy. Norwegian clinicians do not define the routine ultrasound as a screening test (Consensus report of 1995), however, in international literature it is often defined as such. The offer of routine ultrasound is based on womens’ choice. When clinicians and health authorities discuss the option of introducing more routine ultrasound scans in routine practice, they might consider the extension programme in view of requirements that are important in population screening programmes. These include documentation of diagnostic precision, effect of interventions, as well as information about the screening test and how findings are handled.en
dc.description.sponsorshipHelsedirektoratet (tidligere Sosial- og helsedirektoratet)en
dc.publisherNorwegian Knowledge Centre for the Health Servicesen
dc.relation.ispartofseriesRapport fra Kunnskapssentereten
dc.relation.ispartofseriesReport from NOKCen
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gynekologi og obstetrikk: 756en
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Forebyggende medisin: 804en
dc.subject.meshUltrasonography, Prenatalen
dc.titleRutinemessig ultralydundersøkelse i svangerskapetno
dc.typepeer revieweden
dc.contributor.departmentNasjonalt kunnskapssenter for helsetjenestenen
All Items in HeRA are protected by copyright, with all rights reserved, unless otherwise indicated.